WHO ICTRP trial
Study on The Efficacy and Safety of Zhibitai Capsules in Patients with Type 2…
ChiCTR2500109105 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500109105 |
|---|---|
| Public title | Study on The Efficacy and Safety of Zhibitai Capsules in Patients with Type 2 Diabetes and Dyslipidemia |
| Scientific title | Study on The Efficacy and Safety of Zhibitai Capsules in Patients with Type 2 Diabetes and Dyslipidemia |
| Primary sponsor | Shuguang Hospital affiliated with Shanghai University of TCM |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | type 2 diabetes and dyslipidemia |
| Interventions | Intervention Group:Zhibitai Capsules;Control Group:Atorvastatin calcium tablets |
| Registration date | Sep 11, 2025 |
| Target size | Intervention Group:70;Control Group:70 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: